首页 > 最新文献

Chinese Neurosurgical Journal最新文献

英文 中文
Thrombospondin-2 promotes the proliferation and migration of glioma cells and contributes to the progression of glioma. 血小板反应蛋白-2促进胶质瘤细胞的增殖和迁移,促进胶质瘤的进展。
Q2 Medicine Pub Date : 2022-12-07 DOI: 10.1186/s41016-022-00308-x
Tian-Lan Huang, Yi-Wen Mei, Yang Li, Xin Chen, Si-Xun Yu, Yong-Qin Kuang, Hai-Feng Shu

Background: Gliomas, especially high-grade gliomas, are highly malignant with a poor prognosis. Although existing treatments have improved the survival rate of patients with glioma, the recurrence and mortality rates are still not ideal. The molecular mechanisms involved in the occurrence and development of glioma are still poorly understood. We previously reported that thrombospondin-2 (TSP2) expression was increased in tumor specimens from rat models, promoting excitatory synapse formation. However, little is known about the effect of TSP2 on the biological characteristics of glioma.

Methods: Glioma and cerebral cortex tissues were collected from 33 patients, and the expression of TSP2 in them was analyzed. Next, the proliferation and migration of TSP2 on glioma cells were analyzed in vitro. At last, a glioma transplantation model was constructed to explore the growth of TSP2 on glioma in vivo.

Results: The expression of TSP2 in surgical glioma specimens was increased compared to that in the normal cortex. Interestingly, the TSP2 protein level was higher in high-grade glioma (HGG, World Health Organization (WHO) grades 3-4) than in low-grade glioma (LGG, WHO grades 1-2) tissues. Exogenous addition of the TSP2 protein at an appropriate concentration promoted the migration of glioma cells but did not significantly affect their proliferation. Surprisingly, overexpression of TSP2 promoted both the migration and proliferation of cultured glioma cells. Moreover, in vivo experimental data implied that overexpression of TSP2 in C6 cells promoted the malignant growth of gliomas, while knockout of TSP2 slowed glioma growth.

Conclusions: TSP2 promotes the migration and proliferation of glioma cells, which may provide new ideas for blocking glioma progression.

背景:胶质瘤,尤其是高级别胶质瘤,是高度恶性且预后差的疾病。虽然现有的治疗方法提高了胶质瘤患者的生存率,但其复发率和死亡率仍然不理想。胶质瘤发生发展的分子机制尚不清楚。我们之前报道了血栓反应蛋白-2 (TSP2)在大鼠模型肿瘤标本中的表达增加,促进兴奋性突触的形成。然而,关于TSP2对胶质瘤生物学特性的影响知之甚少。方法:收集33例胶质瘤和大脑皮层组织,分析其TSP2的表达情况。接下来,我们在体外分析了TSP2在胶质瘤细胞上的增殖和迁移。最后构建胶质瘤移植模型,探讨TSP2在胶质瘤体内的生长情况。结果:TSP2在脑胶质瘤组织中的表达明显高于正常脑组织。有趣的是,TSP2蛋白水平在高级别胶质瘤(HGG,世界卫生组织分级3-4)中高于低级别胶质瘤(LGG, WHO分级1-2)组织。外源添加适当浓度的TSP2蛋白可促进胶质瘤细胞的迁移,但对胶质瘤细胞的增殖无显著影响。令人惊讶的是,TSP2的过表达促进了培养的胶质瘤细胞的迁移和增殖。此外,体内实验数据表明,C6细胞中过表达TSP2可促进胶质瘤的恶性生长,而敲除TSP2可减缓胶质瘤的生长。结论:TSP2促进胶质瘤细胞的迁移和增殖,可能为阻断胶质瘤的进展提供新的思路。
{"title":"Thrombospondin-2 promotes the proliferation and migration of glioma cells and contributes to the progression of glioma.","authors":"Tian-Lan Huang,&nbsp;Yi-Wen Mei,&nbsp;Yang Li,&nbsp;Xin Chen,&nbsp;Si-Xun Yu,&nbsp;Yong-Qin Kuang,&nbsp;Hai-Feng Shu","doi":"10.1186/s41016-022-00308-x","DOIUrl":"https://doi.org/10.1186/s41016-022-00308-x","url":null,"abstract":"<p><strong>Background: </strong>Gliomas, especially high-grade gliomas, are highly malignant with a poor prognosis. Although existing treatments have improved the survival rate of patients with glioma, the recurrence and mortality rates are still not ideal. The molecular mechanisms involved in the occurrence and development of glioma are still poorly understood. We previously reported that thrombospondin-2 (TSP2) expression was increased in tumor specimens from rat models, promoting excitatory synapse formation. However, little is known about the effect of TSP2 on the biological characteristics of glioma.</p><p><strong>Methods: </strong>Glioma and cerebral cortex tissues were collected from 33 patients, and the expression of TSP2 in them was analyzed. Next, the proliferation and migration of TSP2 on glioma cells were analyzed in vitro. At last, a glioma transplantation model was constructed to explore the growth of TSP2 on glioma in vivo.</p><p><strong>Results: </strong>The expression of TSP2 in surgical glioma specimens was increased compared to that in the normal cortex. Interestingly, the TSP2 protein level was higher in high-grade glioma (HGG, World Health Organization (WHO) grades 3-4) than in low-grade glioma (LGG, WHO grades 1-2) tissues. Exogenous addition of the TSP2 protein at an appropriate concentration promoted the migration of glioma cells but did not significantly affect their proliferation. Surprisingly, overexpression of TSP2 promoted both the migration and proliferation of cultured glioma cells. Moreover, in vivo experimental data implied that overexpression of TSP2 in C6 cells promoted the malignant growth of gliomas, while knockout of TSP2 slowed glioma growth.</p><p><strong>Conclusions: </strong>TSP2 promotes the migration and proliferation of glioma cells, which may provide new ideas for blocking glioma progression.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"39"},"PeriodicalIF":0.0,"publicationDate":"2022-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10695641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease. 颅内动脉粥样硬化性疾病患者血管内治疗后斑块特征。
Q2 Medicine Pub Date : 2022-12-02 DOI: 10.1186/s41016-022-00302-3
Shun Zhang, Junjie Wang, Jun Lu, Peng Qi, Shen Hu, Ximeng Yang, Kunpeng Chen, Daming Wang

Background: Endovascular treatment (EVT) is an alternative option for symptomatic intracranial atherosclerotic disease (ICAD). However, the effect of EVT treatment on ICAD plaques is still unclear. This study describes the ICAD plaque characteristics after EVT treatment and analyzes the effect of different EVT treatments on plaque characteristics.

Method: From 2017 January to 2022 January, ICAD patients who underwent endovascular treatment and had follow-up high-resolution magnetic resonance image (HRMRI) were enrolled in the study. Multiple plaque characteristics, including plaque enhancement, plaque burden, were measured based on preoperative, and follow-up HRMRI. Plaque characteristics and postoperative plaque changes were analyzed between different treatment groups.

Result: Finally, 50 intracranial atherosclerotic plaques in 45 patients were included. Including 28 male patients and 17 female, media age 63.0 years old. Among 50 plaques, 41 received percutaneous angioplasty (including 22 plain balloons and 19 drug-coated balloons (DCB)) and the other 9 underwent stenting. Stenosis rate, plaque burden and eccentricity index at the lesion site were significantly decreased after EVT compared with preoperative periods (p <0.001). And only the DCB group showed a significant reduction in plaque enhancement at follow-up (p < 0.001). No significant preoperative and postoperative changes in other plaque characteristics were found.

Conclusion: EVT treatment could compromise the characteristics of intracranial periarterial atherosclerotic plaques, and DCB treatment may result in a reduction in plaque enhancement after treatment.

背景:血管内治疗(EVT)是治疗症状性颅内动脉粥样硬化疾病(ICAD)的另一种选择。然而,EVT治疗对ICAD斑块的影响尚不清楚。本研究描述了EVT治疗后的ICAD斑块特征,并分析了不同EVT治疗对斑块特征的影响。方法:选取2017年1月至2022年1月接受血管内治疗并随访高分辨率磁共振成像(HRMRI)的ICAD患者为研究对象。在术前和随访HRMRI的基础上测量多种斑块特征,包括斑块增强、斑块负荷。分析不同治疗组斑块特征及术后斑块变化。结果:最终纳入45例患者50个颅内动脉粥样硬化斑块。其中男28例,女17例,中位年龄63.0岁。在50个斑块中,41个接受了经皮血管成形术(包括22个普通球囊和19个药物包被球囊(DCB)),另外9个接受了支架植入术。EVT后病变部位狭窄率、斑块负荷、偏心率指数较术前明显降低(p)。结论:EVT治疗可损害颅内动脉粥样硬化斑块特征,DCB治疗可降低治疗后斑块强化。
{"title":"Plaque characteristics after endovascular treatment in patients with intracranial atherosclerotic disease.","authors":"Shun Zhang,&nbsp;Junjie Wang,&nbsp;Jun Lu,&nbsp;Peng Qi,&nbsp;Shen Hu,&nbsp;Ximeng Yang,&nbsp;Kunpeng Chen,&nbsp;Daming Wang","doi":"10.1186/s41016-022-00302-3","DOIUrl":"https://doi.org/10.1186/s41016-022-00302-3","url":null,"abstract":"<p><strong>Background: </strong>Endovascular treatment (EVT) is an alternative option for symptomatic intracranial atherosclerotic disease (ICAD). However, the effect of EVT treatment on ICAD plaques is still unclear. This study describes the ICAD plaque characteristics after EVT treatment and analyzes the effect of different EVT treatments on plaque characteristics.</p><p><strong>Method: </strong>From 2017 January to 2022 January, ICAD patients who underwent endovascular treatment and had follow-up high-resolution magnetic resonance image (HRMRI) were enrolled in the study. Multiple plaque characteristics, including plaque enhancement, plaque burden, were measured based on preoperative, and follow-up HRMRI. Plaque characteristics and postoperative plaque changes were analyzed between different treatment groups.</p><p><strong>Result: </strong>Finally, 50 intracranial atherosclerotic plaques in 45 patients were included. Including 28 male patients and 17 female, media age 63.0 years old. Among 50 plaques, 41 received percutaneous angioplasty (including 22 plain balloons and 19 drug-coated balloons (DCB)) and the other 9 underwent stenting. Stenosis rate, plaque burden and eccentricity index at the lesion site were significantly decreased after EVT compared with preoperative periods (p <0.001). And only the DCB group showed a significant reduction in plaque enhancement at follow-up (p < 0.001). No significant preoperative and postoperative changes in other plaque characteristics were found.</p><p><strong>Conclusion: </strong>EVT treatment could compromise the characteristics of intracranial periarterial atherosclerotic plaques, and DCB treatment may result in a reduction in plaque enhancement after treatment.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"37"},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10328982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intradural extramedullary cervical metastasis from Merkel cell carcinoma: a case report and literature review. 默克尔细胞癌硬膜内髓外宫颈转移一例报告并文献复习。
Q2 Medicine Pub Date : 2022-12-02 DOI: 10.1186/s41016-022-00310-3
Giovanni Pennisi, Andrea Talacchi, Marcello Nunzio Tirendi, Marco Giordano, Alessandro Olivi

Background: Merkel cell carcinoma (MCC) is a rare aggressive primary skin carcinoma with an incidence of 44 cases per 100,000. The natural course of MCC often results in rapid growth and early metastasis. On the other hand, the spinal cord is rarely affected and frequently features the end stage of the disease. The aim of this paper was to clarify the management of patients with spine metastasis from a skin lesion and showed a case-based update.

Case presentation: A 73-year-old female was admitted to the Neurosurgical Department in December 2021 for a sudden right hemiparesis with bladder dysfunction and a history of cutaneous Merkel cell carcinoma. A magnetic resonance imaging (MRI) of the central nervous system (CNS) showed an intradural-extramedullary right-sided C6-C7 tumor with mass effect and edema of the cervical cord. The patient underwent a C6-C7 laminectomy with microsurgical total resection of the intradural extramedullary lesion. The neuropathological examination identified a metastasis from Merkel cell carcinoma. Nowadays, evidence for spinal metastasis from malignities skin cancer is generally lacking, probably because they are extremely rare. The exact time of life expectancy is controversial, and some clinicians use a cutoff of 3 months to determine whether surgical intervention should be offered, while others advocate at least 6 months of life expectancy.

Conclusions: To the best of our knowledge, we showed the first case of solitary intradural extramedullary cervical spine metastasis from MCC. We recommend to consider metastasis of MCC in the differential diagnosis of spinal metastasis.

背景:默克尔细胞癌(MCC)是一种罕见的侵袭性原发性皮肤癌,发病率为每10万人44例。MCC的自然过程通常导致快速生长和早期转移。另一方面,脊髓很少受到影响,并且经常以疾病的终末期为特征。本文的目的是阐明皮肤病变的脊柱转移患者的管理,并显示了基于病例的更新。病例介绍:一名73岁女性于2021年12月因突发性右半瘫合并膀胱功能障碍和皮肤默克尔细胞癌病史入院神经外科。中枢神经系统(CNS)磁共振成像(MRI)显示硬膜内-髓外右侧C6-C7肿瘤伴团块效应和颈髓水肿。患者行C6-C7椎板切除术,显微手术切除硬膜内髓外病变。神经病理学检查发现默克尔细胞癌转移。目前,恶性皮肤癌脊柱转移的证据普遍缺乏,可能是因为它们极其罕见。预期寿命的确切时间是有争议的,一些临床医生使用3个月的截止时间来确定是否应该进行手术干预,而另一些人则主张至少6个月的预期寿命。结论:据我们所知,我们报道了首例MCC孤立性硬膜内髓外颈椎转移病例。我们建议在脊柱转移的鉴别诊断中考虑MCC的转移。
{"title":"Intradural extramedullary cervical metastasis from Merkel cell carcinoma: a case report and literature review.","authors":"Giovanni Pennisi,&nbsp;Andrea Talacchi,&nbsp;Marcello Nunzio Tirendi,&nbsp;Marco Giordano,&nbsp;Alessandro Olivi","doi":"10.1186/s41016-022-00310-3","DOIUrl":"https://doi.org/10.1186/s41016-022-00310-3","url":null,"abstract":"<p><strong>Background: </strong>Merkel cell carcinoma (MCC) is a rare aggressive primary skin carcinoma with an incidence of 44 cases per 100,000. The natural course of MCC often results in rapid growth and early metastasis. On the other hand, the spinal cord is rarely affected and frequently features the end stage of the disease. The aim of this paper was to clarify the management of patients with spine metastasis from a skin lesion and showed a case-based update.</p><p><strong>Case presentation: </strong>A 73-year-old female was admitted to the Neurosurgical Department in December 2021 for a sudden right hemiparesis with bladder dysfunction and a history of cutaneous Merkel cell carcinoma. A magnetic resonance imaging (MRI) of the central nervous system (CNS) showed an intradural-extramedullary right-sided C6-C7 tumor with mass effect and edema of the cervical cord. The patient underwent a C6-C7 laminectomy with microsurgical total resection of the intradural extramedullary lesion. The neuropathological examination identified a metastasis from Merkel cell carcinoma. Nowadays, evidence for spinal metastasis from malignities skin cancer is generally lacking, probably because they are extremely rare. The exact time of life expectancy is controversial, and some clinicians use a cutoff of 3 months to determine whether surgical intervention should be offered, while others advocate at least 6 months of life expectancy.</p><p><strong>Conclusions: </strong>To the best of our knowledge, we showed the first case of solitary intradural extramedullary cervical spine metastasis from MCC. We recommend to consider metastasis of MCC in the differential diagnosis of spinal metastasis.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"38"},"PeriodicalIF":0.0,"publicationDate":"2022-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716679/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10678682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional outcome of surgical management of low mid-grade lumbar spondylolisthesis when considering the sagittal balance parameters preoperatively: a prospective study. 术前考虑矢状面平衡参数时,手术治疗中低度腰椎滑脱的功能结局:一项前瞻性研究。
Q2 Medicine Pub Date : 2022-11-25 DOI: 10.1186/s41016-022-00303-2
Sameh Elmorsy Hassan Elmorsy, Hazem Abdelsattar Abulnasr, Yousry Hassan, Magdy Samra, Ehab Mohamed Eissa

Background: Prospective study objectives. A sagittal balance is a good tool to improve the functional outcome of spine spondylolisthesis surgeries, primarily noted that it has a good impact in deformity surgery and then applied to every spine surgery and the aim of this study is to evaluate its functional outcome when considered in preoperative planning for non-dysplastic low- and mid-grade spondylolisthesis surgeries.

Method: Forty patients diagnosed as low- or mid-grade non-dysplastic spondylolisthesis had undergone surgery at Cairo University after failed medical treatment had been evaluated preoperatively by measuring the sagittal balance parameters which include SVA, spinopelvic angles, lumbar lordosis, pelvic tilt, sacral slope, and pelvic incidence and then measure it along a follow-up period of 1 year postoperatively started from February 2018 and correlate it with functional outcome using Oswestry score (ODI)and VAS. Correction of parameters has been estimated preoperatively by manual estimation and Surgimap application then applied during the operation.

Results: All patients were treated by surgical treatment through posterior transpedicular screw fixation with conventional or reduction screws and fusion ± TLIF cages. The mean of lumbar lordosis and mean spinopelvic angles were increased in a statistically significant manner. Pelvis tilt was decreased in a statistically insignificant manner. The mean of pelvic incidence was not changed and statistically insignificant, and this is matching the fact that pelvic incidence is a constant parameter. The sacral slope was increased in a statistically insignificant manner. Final results showed that 37 had a statistically significant improvement in their ODI >20% at the last visit. Three patients had a poor clinical outcome with ODI scorFinal results showed that 37 had a statistically significant improvement in their ODI >20% at the last visit. Three patients had a poor clinical outcome with ODI score of >20% improvement, and we noticed that the level of pathology was at the level of L4L5, SVA was positive and worsen postoperatively, and also, it is accompanied by decreased lumbar lordosis. Change in ODI means statistically significant improvement when considering sagittal parameters preoperation and during operation.

Conclusion: Sagittal balance parameters should be considered in the surgical management of low-grade spondylolisthesis cases to improve their functional outcome.

背景:前瞻性研究目的。矢状面平衡是改善脊柱滑脱手术功能结果的一个很好的工具,首先注意到它在畸形手术中有很好的影响,然后应用于每一种脊柱手术,本研究的目的是在非发育不良的中低度脊柱滑脱手术的术前规划中考虑其功能结果。方法:40例诊断为中低度非发育不良性椎体滑脱的患者在开罗大学接受了手术治疗,术前通过测量矢状面平衡参数(包括SVA、脊柱-骨盆角、腰椎前凸、骨盆倾斜、骶骨斜度)进行了评估。和盆腔发生率,然后从2018年2月开始随访1年,并使用Oswestry评分(ODI)和VAS将其与功能结局相关联。术前通过人工估计和应用Surgimap对参数的校正进行估计,然后在手术期间应用。结果:所有患者均行常规螺钉或复位螺钉后经椎弓根螺钉内固定+融合+ TLIF笼手术治疗。腰椎前凸的平均值和脊柱骨盆角的平均值均有统计学意义的增加。骨盆倾斜降低,但统计学上不显著。盆腔发病率的平均值没有变化,统计学上不显著,这与盆腔发病率是一个恒定参数的事实相匹配。骶骨斜率增加,但无统计学意义。最终结果显示,37例患者的ODI在最后一次就诊时有统计学意义上的显著改善>20%。3例患者ODI评分较差,最终结果显示,37例患者在最后一次就诊时ODI改善>20%,具有统计学意义。3例患者临床预后较差,ODI评分改善>20%,我们注意到病理水平在L4L5水平,SVA阳性且术后加重,同时伴有腰椎前凸减小。在术前和术中考虑矢状面参数时,ODI的改变意味着统计学上显著的改善。结论:在低程度滑脱的手术治疗中应考虑矢状位平衡参数,以改善其功能预后。
{"title":"Functional outcome of surgical management of low mid-grade lumbar spondylolisthesis when considering the sagittal balance parameters preoperatively: a prospective study.","authors":"Sameh Elmorsy Hassan Elmorsy,&nbsp;Hazem Abdelsattar Abulnasr,&nbsp;Yousry Hassan,&nbsp;Magdy Samra,&nbsp;Ehab Mohamed Eissa","doi":"10.1186/s41016-022-00303-2","DOIUrl":"https://doi.org/10.1186/s41016-022-00303-2","url":null,"abstract":"<p><strong>Background: </strong>Prospective study objectives. A sagittal balance is a good tool to improve the functional outcome of spine spondylolisthesis surgeries, primarily noted that it has a good impact in deformity surgery and then applied to every spine surgery and the aim of this study is to evaluate its functional outcome when considered in preoperative planning for non-dysplastic low- and mid-grade spondylolisthesis surgeries.</p><p><strong>Method: </strong>Forty patients diagnosed as low- or mid-grade non-dysplastic spondylolisthesis had undergone surgery at Cairo University after failed medical treatment had been evaluated preoperatively by measuring the sagittal balance parameters which include SVA, spinopelvic angles, lumbar lordosis, pelvic tilt, sacral slope, and pelvic incidence and then measure it along a follow-up period of 1 year postoperatively started from February 2018 and correlate it with functional outcome using Oswestry score (ODI)and VAS. Correction of parameters has been estimated preoperatively by manual estimation and Surgimap application then applied during the operation.</p><p><strong>Results: </strong>All patients were treated by surgical treatment through posterior transpedicular screw fixation with conventional or reduction screws and fusion ± TLIF cages. The mean of lumbar lordosis and mean spinopelvic angles were increased in a statistically significant manner. Pelvis tilt was decreased in a statistically insignificant manner. The mean of pelvic incidence was not changed and statistically insignificant, and this is matching the fact that pelvic incidence is a constant parameter. The sacral slope was increased in a statistically insignificant manner. Final results showed that 37 had a statistically significant improvement in their ODI >20% at the last visit. Three patients had a poor clinical outcome with ODI scorFinal results showed that 37 had a statistically significant improvement in their ODI >20% at the last visit. Three patients had a poor clinical outcome with ODI score of >20% improvement, and we noticed that the level of pathology was at the level of L4L5, SVA was positive and worsen postoperatively, and also, it is accompanied by decreased lumbar lordosis. Change in ODI means statistically significant improvement when considering sagittal parameters preoperation and during operation.</p><p><strong>Conclusion: </strong>Sagittal balance parameters should be considered in the surgical management of low-grade spondylolisthesis cases to improve their functional outcome.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700965/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10337876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic surgery versus craniotomy in the treatment of spontaneous intracerebral hematoma: a systematic review and meta-analysis. 内窥镜手术与开颅术治疗自发性脑内血肿:一项系统回顾和荟萃分析。
Q2 Medicine Pub Date : 2022-11-25 DOI: 10.1186/s41016-022-00304-1
Xiaolin Du, Xiaoning Lin, Cheng Wang, Kun Zhou, Yigong Wei, Xinhua Tian

Background: Spontaneous intracerebral hemorrhage (SICH) has high morbidity and mortality, with no clear standard of treatment available. Compared with the craniotomy approach, neuroendoscopy is a relatively minimally invasive treatment method, and may be an efficient alternative. Therefore, this meta-analysis aimed to assess the clinical efficacy of neuroendoscopy and craniotomy in SICH patients.

Methods: The electronic databases Web of Science, PubMed, EmBase, MEDLINE, and the Cochrane Library were systematically searched. According to the PRISMA template, we finally selected and analyzed 14 eligible studies that evaluated neuroendoscopy versus craniotomy. Primary outcomes included operation time, intraoperative blood loss volume, evacuation rate, residual hematoma, complications, hospital stay duration, clinical outcomes, and other parameters.

Results: A total of 4 randomized controlled trials (RCTs) and 10 retrospective studies (non-RCTs) involving 1652 patients were included in the final analysis. In the neuroendoscopy (NE) group, operation time (p < 0.00001), intraoperative blood loss volume (p < 0.0001), hematoma evacuation rate (p = 0.0002), complications (p < 0.00001), hospitalization days (p = 0.004), and mortality (p < 0.0001) were significantly different from those of the craniotomy (C) group, with a higher rate of good recovery compared with the craniotomy group (P < 0.00001).

Conclusions: These findings suggest that patients with SICH and physicians may benefit more from neuroendoscopic surgery than craniotomy.

背景:自发性脑出血(siich)具有高发病率和死亡率,目前尚无明确的治疗标准。与开颅手术相比,神经内窥镜是一种相对微创的治疗方法,可能是一种有效的替代方法。因此,本荟萃分析旨在评估神经内窥镜和开颅术在脑出血患者中的临床疗效。方法:系统检索Web of Science、PubMed、EmBase、MEDLINE、Cochrane Library等电子数据库。根据PRISMA模板,我们最终选择并分析了14项评估神经内窥镜与开颅手术的合格研究。主要结局包括手术时间、术中出血量、疏散率、残留血肿、并发症、住院时间、临床结局等参数。结果:最终分析共纳入4项随机对照试验(rct)和10项回顾性研究(非rct),共1652例患者。神经内镜(NE)组手术时间(p < 0.00001)、术中出血量(p < 0.0001)、血肿排出率(p = 0.0002)、并发症(p < 0.00001)、住院天数(p = 0.004)、病死率(p < 0.0001)均显著高于开颅(C)组,良好恢复率高于开颅组(p < 0.00001)。结论:这些发现表明,SICH患者和医生可能从神经内窥镜手术中比开颅手术获益更多。
{"title":"Endoscopic surgery versus craniotomy in the treatment of spontaneous intracerebral hematoma: a systematic review and meta-analysis.","authors":"Xiaolin Du,&nbsp;Xiaoning Lin,&nbsp;Cheng Wang,&nbsp;Kun Zhou,&nbsp;Yigong Wei,&nbsp;Xinhua Tian","doi":"10.1186/s41016-022-00304-1","DOIUrl":"https://doi.org/10.1186/s41016-022-00304-1","url":null,"abstract":"<p><strong>Background: </strong>Spontaneous intracerebral hemorrhage (SICH) has high morbidity and mortality, with no clear standard of treatment available. Compared with the craniotomy approach, neuroendoscopy is a relatively minimally invasive treatment method, and may be an efficient alternative. Therefore, this meta-analysis aimed to assess the clinical efficacy of neuroendoscopy and craniotomy in SICH patients.</p><p><strong>Methods: </strong>The electronic databases Web of Science, PubMed, EmBase, MEDLINE, and the Cochrane Library were systematically searched. According to the PRISMA template, we finally selected and analyzed 14 eligible studies that evaluated neuroendoscopy versus craniotomy. Primary outcomes included operation time, intraoperative blood loss volume, evacuation rate, residual hematoma, complications, hospital stay duration, clinical outcomes, and other parameters.</p><p><strong>Results: </strong>A total of 4 randomized controlled trials (RCTs) and 10 retrospective studies (non-RCTs) involving 1652 patients were included in the final analysis. In the neuroendoscopy (NE) group, operation time (p < 0.00001), intraoperative blood loss volume (p < 0.0001), hematoma evacuation rate (p = 0.0002), complications (p < 0.00001), hospitalization days (p = 0.004), and mortality (p < 0.0001) were significantly different from those of the craniotomy (C) group, with a higher rate of good recovery compared with the craniotomy group (P < 0.00001).</p><p><strong>Conclusions: </strong>These findings suggest that patients with SICH and physicians may benefit more from neuroendoscopic surgery than craniotomy.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701065/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10388642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development. 鉴定肿瘤相关抗原和低级别胶质瘤和胶质母细胞瘤的免疫亚型用于mRNA疫苗的开发。
Q2 Medicine Pub Date : 2022-10-28 DOI: 10.1186/s41016-022-00301-4
Zhi-Liang Wang, Ruo-Yu Huang, Bo Han, Fan Wu, Zhi-Yan Sun, Guan-Zhang Li, Wei Zhang, Zheng Zhao, Xing Liu

Background: mRNA became a promising therapeutic approach in many diseases. This study aimed to identify the tumor antigens specifically expressed in tumor cells for lower-grade glioma (LGG) and glioblastoma (GBM) patients.

Methods: In this work, the mRNA microarray expression profile and clinical data were obtained from 301 samples in the Chinese Glioma Genome Atlas (CGGA) database, the mRNA sequencing data and clinical data of 701 samples were downloaded from The Cancer Genome Atlas (TCGA) database. Genetic alterations profiles were extracted from CGGA and cBioPortal datasets. R language and GraphPad Prism software were applied for the statistical analysis and graph work.

Results: PTBP1 and SLC39A1, which were overexpressed and indicated poor prognosis in LGG patients, were selected as tumor-specific antigens for LGG patients. Meanwhile, MMP9 and SLC16A3, the negative prognostic factors overexpressed in GBM, were identified as tumor-specific antigens for GBM patients. Besides, three immune subtypes (LGG1-LGG3) and eight WGCNA modules were identified in LGG patients. Meanwhile, two immune subtypes (GBM1-GBM2) and 10 WGCNA modules were selected in GBM. The immune characteristics and potential functions between different subtypes were diversity. LGG2 and GBM1 immune subtype were associated with longer overall survival than other subtypes.

Conclusion: In this study, PTBP1 and SLC39A1 are promising antigens for mRNA vaccines development in LGG, and MMP9 and SLC16A3 were potential antigens in GBM. Our analyses indicated that mRNA vaccine immunotherapy was more suitable for LGG2 and GBM1 subtypes. This study was helpful for the development of glioma immunotherapies.

背景:mRNA已成为许多疾病的一种有前景的治疗方法。本研究旨在鉴定低级别胶质瘤(LGG)和胶质母细胞瘤(GBM)患者肿瘤细胞中特异性表达的肿瘤抗原。方法:从中国胶质瘤基因组图谱(CGGA)数据库中获取301份样本的mRNA微阵列表达谱和临床数据,从癌症基因组图谱(TCGA)数据库中下载701份样本的mRNA测序数据和临床数据。从CGGA和cBioPortal数据集中提取遗传改变谱。采用R语言和GraphPad Prism软件进行统计分析和绘图。结果:选择LGG患者中过表达、预后不良的PTBP1和SLC39A1作为LGG患者的肿瘤特异性抗原。同时,在GBM中过表达的阴性预后因子MMP9和SLC16A3被鉴定为GBM患者的肿瘤特异性抗原。此外,在LGG患者中鉴定出3种免疫亚型(LGG1-LGG3)和8种WGCNA模块。同时,在GBM中选择2个免疫亚型(GBM1-GBM2)和10个WGCNA模块。不同亚型之间的免疫特性和潜在功能存在差异。与其他亚型相比,LGG2和GBM1免疫亚型与更长的总生存期相关。结论:在本研究中,PTBP1和SLC39A1是LGG mRNA疫苗的潜在抗原,MMP9和SLC16A3是GBM的潜在抗原。我们的分析表明mRNA疫苗免疫治疗更适合LGG2和GBM1亚型。本研究有助于胶质瘤免疫治疗的发展。
{"title":"Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development.","authors":"Zhi-Liang Wang,&nbsp;Ruo-Yu Huang,&nbsp;Bo Han,&nbsp;Fan Wu,&nbsp;Zhi-Yan Sun,&nbsp;Guan-Zhang Li,&nbsp;Wei Zhang,&nbsp;Zheng Zhao,&nbsp;Xing Liu","doi":"10.1186/s41016-022-00301-4","DOIUrl":"https://doi.org/10.1186/s41016-022-00301-4","url":null,"abstract":"<p><strong>Background: </strong>mRNA became a promising therapeutic approach in many diseases. This study aimed to identify the tumor antigens specifically expressed in tumor cells for lower-grade glioma (LGG) and glioblastoma (GBM) patients.</p><p><strong>Methods: </strong>In this work, the mRNA microarray expression profile and clinical data were obtained from 301 samples in the Chinese Glioma Genome Atlas (CGGA) database, the mRNA sequencing data and clinical data of 701 samples were downloaded from The Cancer Genome Atlas (TCGA) database. Genetic alterations profiles were extracted from CGGA and cBioPortal datasets. R language and GraphPad Prism software were applied for the statistical analysis and graph work.</p><p><strong>Results: </strong>PTBP1 and SLC39A1, which were overexpressed and indicated poor prognosis in LGG patients, were selected as tumor-specific antigens for LGG patients. Meanwhile, MMP9 and SLC16A3, the negative prognostic factors overexpressed in GBM, were identified as tumor-specific antigens for GBM patients. Besides, three immune subtypes (LGG1-LGG3) and eight WGCNA modules were identified in LGG patients. Meanwhile, two immune subtypes (GBM1-GBM2) and 10 WGCNA modules were selected in GBM. The immune characteristics and potential functions between different subtypes were diversity. LGG2 and GBM1 immune subtype were associated with longer overall survival than other subtypes.</p><p><strong>Conclusion: </strong>In this study, PTBP1 and SLC39A1 are promising antigens for mRNA vaccines development in LGG, and MMP9 and SLC16A3 were potential antigens in GBM. Our analyses indicated that mRNA vaccine immunotherapy was more suitable for LGG2 and GBM1 subtypes. This study was helpful for the development of glioma immunotherapies.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":" ","pages":"34"},"PeriodicalIF":0.0,"publicationDate":"2022-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614757/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40652872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Multimodality treatment for brain arteriovenous malformation in Mainland China: design, rationale, and baseline patient characteristics of a nationwide multicenter prospective registry. 中国大陆脑动静脉畸形的多模式治疗:全国多中心前瞻性登记的设计、基本原理和基线患者特征。
Q2 Medicine Pub Date : 2022-10-17 DOI: 10.1186/s41016-022-00296-y
Yu Chen, Heze Han, Li Ma, Ruinan Li, Zhipeng Li, Debin Yan, Haibin Zhang, Kexin Yuan, Ke Wang, Yang Zhao, Yukun Zhang, Weitao Jin, Runting Li, Fa Lin, Xiangyu Meng, Qiang Hao, Hao Wang, Xun Ye, Shuai Kang, Hengwei Jin, Youxiang Li, Dezhi Gao, Shibin Sun, Ali Liu, Shuo Wang, Xiaolin Chen, Yuanli Zhao

Background: Brain arteriovenous malformation (AVM) is an important cause of hemorrhagic stroke in young adults, which can lead to severe neurological impairment. The registry of Multimodality treatment for brain ArTeriovenous malformation in mainland CHina (MATCH) is a national prospective registry to identify the natural history of AVMs in Asian population; to investigate traditional and emerging hemorrhagic predictors; and to explore the superiority of the multidisciplinary assessment in improving the long-term outcomes.  METHODS: Consecutive AVM patients will be enrolled from 52 participating hospitals in mainland China. Baseline demographic, clinical and imaging data will be collected prospectively. Conservation, microsurgery, embolization, stereotactic radiosurgery (SRS), and multimodal strategies are all included in this study. Patients will be divided into experimental and control group according to whether the treatment protocols are formulated by multidisciplinary team. Neurofunctional status, subsequent hemorrhage, seizure, and novel neurofunctional deficit will be queried at 3 months, annually (1 and 2 years), 3 years, and 10 years follow-up.

Results: Between August 2011 and April 2021, 3241 AVMs were enrolled in 11 participating sites. Among them, 59.0% were male with an average age of 28.4 ± 14.6 years, 61.2% had rupture history and 2268 hemorrhagic events occurred before admission. The median Spetzler-Martin grade and Lawton-Young grade was 3 and 5, respectively. Microsurgery is the dominant strategy (35.7%), with a similar proportion of embolization, SRS, and a combination of both (12.7%; 14.8%; 11.8%; respectively). Among them, 15.43% underwent multidisciplinary assessment and received standardized treatment. At the most recent follow-up, 7.8% were lost and the median follow-up duration was 5.6 years.

Conclusions: The MATCH study is a large-sample nationwide prospective registry to investigate multimodality management strategy for AVMs. Data from this registry may also provide the opportunity for individualized risk assessment and the development of optimal individual management strategies.

Trial registration: ClinicalTrials.gov Registry ( NCT04572568 ).

背景:脑动静脉畸形(AVM)是青壮年出血性脑卒中的重要病因,可导致严重的神经功能损害。中国大陆脑动静脉畸形多模式治疗登记(MATCH)是一项国家前瞻性登记,旨在确定亚洲人群中avm的自然史;探讨传统的和新兴的出血预测指标;探讨多学科评估在改善远期疗效方面的优势。方法:从中国大陆52家参与研究的医院连续招募AVM患者。将前瞻性地收集基线人口统计学、临床和影像学数据。保护、显微手术、栓塞、立体定向放射手术(SRS)和多模式策略都包括在本研究中。根据是否由多学科团队制定治疗方案,将患者分为实验组和对照组。在随访3个月、每年(1年和2年)、3年和10年时询问神经功能状态、随后的出血、癫痫发作和新的神经功能缺陷。结果:2011年8月至2021年4月,共有3241例avm在11个参与站点被纳入研究。其中男性占59.0%,平均年龄28.4±14.6岁,有破裂史61.2%,入院前发生出血事件2268起。Spetzler-Martin评分中位数为3分,Lawton-Young评分中位数为5分。显微手术是主要策略(35.7%),栓塞、SRS和两者结合的比例相似(12.7%;14.8%;11.8%;分别)。其中15.43%的患者接受了多学科评估和规范化治疗。在最近的随访中,7.8%的患者丢失,中位随访时间为5.6年。结论:MATCH研究是一项大样本的全国性前瞻性注册研究,旨在研究avm的多模式管理策略。来自该登记处的数据也可能为个体化风险评估和制定最佳个人管理战略提供机会。试验注册:ClinicalTrials.gov注册中心(NCT04572568)。
{"title":"Multimodality treatment for brain arteriovenous malformation in Mainland China: design, rationale, and baseline patient characteristics of a nationwide multicenter prospective registry.","authors":"Yu Chen,&nbsp;Heze Han,&nbsp;Li Ma,&nbsp;Ruinan Li,&nbsp;Zhipeng Li,&nbsp;Debin Yan,&nbsp;Haibin Zhang,&nbsp;Kexin Yuan,&nbsp;Ke Wang,&nbsp;Yang Zhao,&nbsp;Yukun Zhang,&nbsp;Weitao Jin,&nbsp;Runting Li,&nbsp;Fa Lin,&nbsp;Xiangyu Meng,&nbsp;Qiang Hao,&nbsp;Hao Wang,&nbsp;Xun Ye,&nbsp;Shuai Kang,&nbsp;Hengwei Jin,&nbsp;Youxiang Li,&nbsp;Dezhi Gao,&nbsp;Shibin Sun,&nbsp;Ali Liu,&nbsp;Shuo Wang,&nbsp;Xiaolin Chen,&nbsp;Yuanli Zhao","doi":"10.1186/s41016-022-00296-y","DOIUrl":"https://doi.org/10.1186/s41016-022-00296-y","url":null,"abstract":"<p><strong>Background: </strong>Brain arteriovenous malformation (AVM) is an important cause of hemorrhagic stroke in young adults, which can lead to severe neurological impairment. The registry of Multimodality treatment for brain ArTeriovenous malformation in mainland CHina (MATCH) is a national prospective registry to identify the natural history of AVMs in Asian population; to investigate traditional and emerging hemorrhagic predictors; and to explore the superiority of the multidisciplinary assessment in improving the long-term outcomes.  METHODS: Consecutive AVM patients will be enrolled from 52 participating hospitals in mainland China. Baseline demographic, clinical and imaging data will be collected prospectively. Conservation, microsurgery, embolization, stereotactic radiosurgery (SRS), and multimodal strategies are all included in this study. Patients will be divided into experimental and control group according to whether the treatment protocols are formulated by multidisciplinary team. Neurofunctional status, subsequent hemorrhage, seizure, and novel neurofunctional deficit will be queried at 3 months, annually (1 and 2 years), 3 years, and 10 years follow-up.</p><p><strong>Results: </strong>Between August 2011 and April 2021, 3241 AVMs were enrolled in 11 participating sites. Among them, 59.0% were male with an average age of 28.4 ± 14.6 years, 61.2% had rupture history and 2268 hemorrhagic events occurred before admission. The median Spetzler-Martin grade and Lawton-Young grade was 3 and 5, respectively. Microsurgery is the dominant strategy (35.7%), with a similar proportion of embolization, SRS, and a combination of both (12.7%; 14.8%; 11.8%; respectively). Among them, 15.43% underwent multidisciplinary assessment and received standardized treatment. At the most recent follow-up, 7.8% were lost and the median follow-up duration was 5.6 years.</p><p><strong>Conclusions: </strong>The MATCH study is a large-sample nationwide prospective registry to investigate multimodality management strategy for AVMs. Data from this registry may also provide the opportunity for individualized risk assessment and the development of optimal individual management strategies.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov Registry ( NCT04572568 ).</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":"8 1","pages":"33"},"PeriodicalIF":0.0,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575306/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9303232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Ultrasound parameters associated with stroke in patients with moyamoya disease: a logistic regression analysis. 烟雾病患者脑卒中与超声参数相关:logistic回归分析
Q2 Medicine Pub Date : 2022-10-11 DOI: 10.1186/s41016-022-00300-5
Shuai Zheng, Fumin Wang, Linggang Cheng, Rui Li, Dong Zhang, Wen He, Wei Zhang

Background: Moyamoya disease can lead to stroke with devastating consequences, it is necessary to find a non-invasive and effective approach to identify the occurrence of stroke. In this study, we aim to analyze the association between ultrasound parameters and ipsilateral cerebral hemisphere stroke in patients with moyamoya disease by logistic regression analysis.

Methods: In this retrospective case-control study, 88 patients with MMD (153 cerebral hemispheres) hospitalized in Beijing Tiantan Hospital, Capital Medical University from November 2020 to October 2021 were analyzed. According to the occurrence of stroke, the 153 cerebral hemispheres were divided into a stroke group and a non-stroke group. Clinical data and ultrasound parameters of the ipsilateral internal carotid artery, superficial temporal artery, maxillary artery, and posterior cerebral artery were recorded. The ultrasound parameters were divided into four groups according to interquartile range, and then they were compared between the stroke group and the non-stroke group. Those with significant differences were scored by multivariate logistic regression analysis.

Results: There were 75 cerebral hemispheres (49.0%) in the stroke group and 78 cerebral hemispheres (51.0%) in the non-stroke group. Logistic regression analysis showed that the internal diameter of the internal carotid artery, peak systolic velocity of the internal carotid artery and peak systolic velocity of the posterior cerebral artery were independently correlated factors for stroke in patients with MMD. The fourth quartile group of the above three ultrasound parameters was taken as the reference group, and the odds ratio of the first quartile group were 11.679 (95% CI 2.918-46.749, P = 0.001), 19.594 (95% CI 4.973-77.193, P < 0.001), and 11.657 (95% CI 3.221-42.186, P < 0.001), respectively.

Conclusion: Ultrasound parameters are independently correlated with ipsilateral cerebral stroke in patients with MMD. Ultrasound provides a new way to identify stroke in MMD patients. Future prospective cohort studies are needed to verify the clinical value of ultrasound in identifying patients with MMD at high risk of stroke.

背景:烟雾病可导致脑卒中,具有毁灭性的后果,有必要寻找一种无创有效的方法来识别脑卒中的发生。在这项研究中,我们旨在通过logistic回归分析超声参数与烟雾病患者同侧大脑半球卒中的关系。方法:对2020年11月至2021年10月首都医科大学附属北京天坛医院住院的烟雾病患者88例(153个大脑半球)进行回顾性病例对照研究。根据中风的发生情况,将153个大脑半球分为中风组和非中风组。记录同侧颈内动脉、颞浅动脉、上颌动脉、大脑后动脉的临床资料及超声参数。将超声参数按四分位数范围分为四组,比较脑卒中组与非脑卒中组的超声参数。对差异显著者进行多因素logistic回归分析。结果:脑卒中组有75个脑半球(49.0%),非脑卒中组有78个脑半球(51.0%)。Logistic回归分析显示,颈内动脉内径、颈内动脉收缩峰值速度、大脑后动脉收缩峰值速度是烟雾病患者脑卒中的独立相关因素。以上述3项超声参数的第4四分位数组为参照组,第1四分位数组的比值比分别为11.679 (95% CI 2.918 ~ 46.749, P = 0.001)、19.594 (95% CI 4.973 ~ 77.193), P结论:超声参数与烟雾病患者同侧脑卒中独立相关。超声诊断为烟雾病患者卒中提供了一种新的诊断方法。未来的前瞻性队列研究需要验证超声在识别烟雾病患者卒中高危人群中的临床价值。
{"title":"Ultrasound parameters associated with stroke in patients with moyamoya disease: a logistic regression analysis.","authors":"Shuai Zheng,&nbsp;Fumin Wang,&nbsp;Linggang Cheng,&nbsp;Rui Li,&nbsp;Dong Zhang,&nbsp;Wen He,&nbsp;Wei Zhang","doi":"10.1186/s41016-022-00300-5","DOIUrl":"https://doi.org/10.1186/s41016-022-00300-5","url":null,"abstract":"<p><strong>Background: </strong>Moyamoya disease can lead to stroke with devastating consequences, it is necessary to find a non-invasive and effective approach to identify the occurrence of stroke. In this study, we aim to analyze the association between ultrasound parameters and ipsilateral cerebral hemisphere stroke in patients with moyamoya disease by logistic regression analysis.</p><p><strong>Methods: </strong>In this retrospective case-control study, 88 patients with MMD (153 cerebral hemispheres) hospitalized in Beijing Tiantan Hospital, Capital Medical University from November 2020 to October 2021 were analyzed. According to the occurrence of stroke, the 153 cerebral hemispheres were divided into a stroke group and a non-stroke group. Clinical data and ultrasound parameters of the ipsilateral internal carotid artery, superficial temporal artery, maxillary artery, and posterior cerebral artery were recorded. The ultrasound parameters were divided into four groups according to interquartile range, and then they were compared between the stroke group and the non-stroke group. Those with significant differences were scored by multivariate logistic regression analysis.</p><p><strong>Results: </strong>There were 75 cerebral hemispheres (49.0%) in the stroke group and 78 cerebral hemispheres (51.0%) in the non-stroke group. Logistic regression analysis showed that the internal diameter of the internal carotid artery, peak systolic velocity of the internal carotid artery and peak systolic velocity of the posterior cerebral artery were independently correlated factors for stroke in patients with MMD. The fourth quartile group of the above three ultrasound parameters was taken as the reference group, and the odds ratio of the first quartile group were 11.679 (95% CI 2.918-46.749, P = 0.001), 19.594 (95% CI 4.973-77.193, P < 0.001), and 11.657 (95% CI 3.221-42.186, P < 0.001), respectively.</p><p><strong>Conclusion: </strong>Ultrasound parameters are independently correlated with ipsilateral cerebral stroke in patients with MMD. Ultrasound provides a new way to identify stroke in MMD patients. Future prospective cohort studies are needed to verify the clinical value of ultrasound in identifying patients with MMD at high risk of stroke.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":" ","pages":"32"},"PeriodicalIF":0.0,"publicationDate":"2022-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555074/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33523529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and outcomes of postoperative stroke in surgical treatment for giant intracranial aneurysms. 颅内巨动脉瘤手术治疗后卒中的危险因素及预后。
Q2 Medicine Pub Date : 2022-10-03 DOI: 10.1186/s41016-022-00297-x
Hao Wang, Junlin Lu, Xin Chen, Qiang Hao

Background: Giant intracranial aneurysms (GIAs) are challenges for surgical treatment. Risk factors of postoperative stroke remain unclear. This study aims to investigate the predictors of postoperative stroke in GIAs and the impact of stroke on outcomes.

Methods: We performed a retrospective medical record review of patients with GIAs who received microsurgery at our institution between 2011 and 2018. Multivariate logistic regression analyses were carried out to identify risk factors for postoperative stroke. The clinical and angiographic outcomes were compared between patients with and without stroke.

Results: A total of 97 patients were included in this study. Surgical modalities included direct aneurysm neck clipping in 85 patients (87.7%), trapping with the bypass in 8 (8.2%), proximal artery ligation in 1 (1%), and bypass alone in 3 (3.1%). Postoperative stroke was found in 26 patients (26.8%). Independent factors that affect postoperative stroke were recurrent aneurysm (OR, 10.982; 95% CI, 1.976-61.045; P = 0.006) and size ≥ 3.5 cm (OR, 3.420; 95% CI, 1.133-10.327; P = 0.029). Combined perioperative mortality and morbidity was 26.8%. Follow-up was achieved from 89 patients (91.8%), with a mean follow-up period of 39 months (range 19 to 94 months). Good outcomes were observed in 75 patients (84.3%) and poor outcomes were observed in 14 patients (15.7%).

Conclusions: Postoperative stroke was significantly associated with clinical outcome. Favorable outcomes can be achieved in most patients with GIAs after appropriate microsurgical modality. Recurrent aneurysm and size ≥ 3.5 cm are risk factors of postoperative stroke.

背景:颅内巨动脉瘤(GIAs)是外科治疗的挑战。术后卒中的危险因素尚不清楚。本研究旨在探讨GIAs术后卒中的预测因素以及卒中对预后的影响。方法:我们对2011年至2018年在我院接受显微手术的GIAs患者进行了回顾性医疗记录回顾。进行多因素logistic回归分析以确定术后卒中的危险因素。比较有和无脑卒中患者的临床和血管造影结果。结果:本研究共纳入97例患者。手术方式包括85例(87.7%)动脉瘤颈直接夹闭,8例(8.2%)搭桥,1例(1%)近端动脉结扎,3例(3.1%)单纯搭桥。术后卒中26例(26.8%)。影响术后卒中的独立因素为复发性动脉瘤(OR, 10.982;95% ci, 1.976-61.045;P = 0.006),尺寸≥3.5 cm (OR, 3.420;95% ci, 1.133-10.327;p = 0.029)。围手术期总死亡率和发病率为26.8%。89例患者(91.8%)获得随访,平均随访时间39个月(19 ~ 94个月)。75例(84.3%)患者预后良好,14例(15.7%)患者预后不良。结论:术后卒中与临床预后显著相关。大多数GIAs患者在适当的显微手术方式后可获得良好的结果。动脉瘤复发及尺寸≥3.5 cm是术后卒中的危险因素。
{"title":"Risk factors and outcomes of postoperative stroke in surgical treatment for giant intracranial aneurysms.","authors":"Hao Wang,&nbsp;Junlin Lu,&nbsp;Xin Chen,&nbsp;Qiang Hao","doi":"10.1186/s41016-022-00297-x","DOIUrl":"https://doi.org/10.1186/s41016-022-00297-x","url":null,"abstract":"<p><strong>Background: </strong>Giant intracranial aneurysms (GIAs) are challenges for surgical treatment. Risk factors of postoperative stroke remain unclear. This study aims to investigate the predictors of postoperative stroke in GIAs and the impact of stroke on outcomes.</p><p><strong>Methods: </strong>We performed a retrospective medical record review of patients with GIAs who received microsurgery at our institution between 2011 and 2018. Multivariate logistic regression analyses were carried out to identify risk factors for postoperative stroke. The clinical and angiographic outcomes were compared between patients with and without stroke.</p><p><strong>Results: </strong>A total of 97 patients were included in this study. Surgical modalities included direct aneurysm neck clipping in 85 patients (87.7%), trapping with the bypass in 8 (8.2%), proximal artery ligation in 1 (1%), and bypass alone in 3 (3.1%). Postoperative stroke was found in 26 patients (26.8%). Independent factors that affect postoperative stroke were recurrent aneurysm (OR, 10.982; 95% CI, 1.976-61.045; P = 0.006) and size ≥ 3.5 cm (OR, 3.420; 95% CI, 1.133-10.327; P = 0.029). Combined perioperative mortality and morbidity was 26.8%. Follow-up was achieved from 89 patients (91.8%), with a mean follow-up period of 39 months (range 19 to 94 months). Good outcomes were observed in 75 patients (84.3%) and poor outcomes were observed in 14 patients (15.7%).</p><p><strong>Conclusions: </strong>Postoperative stroke was significantly associated with clinical outcome. Favorable outcomes can be achieved in most patients with GIAs after appropriate microsurgical modality. Recurrent aneurysm and size ≥ 3.5 cm are risk factors of postoperative stroke.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":" ","pages":"31"},"PeriodicalIF":0.0,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40389622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms. Enterprise 2支架辅助线圈栓塞治疗颅内宽颈动脉瘤的疗效。
Q2 Medicine Pub Date : 2022-10-02 DOI: 10.1186/s41016-022-00298-w
Yangyang Zhou, Qichen Peng, Shiqing Mu

Background: This study analyzed the safety and efficacy of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms by examining stent-vessel apposition, operative complications, embolization outcomes, and clinical outcomes.

Methods: We retrospectively reviewed the medical records of patients with wide-necked intracranial aneurysms who underwent Enterprise 2 stent-assisted coiling in our hospital from November 2018 to October 2019. Intraoperative VasoCT was performed immediately after stent release in a continuous cohort of patients to observe stent-vessel apposition. Patient demographic, clinical, and imaging data were recorded and analyzed.

Results: A total of 106 wide-necked aneurysms in 106 patients were treated. Stent release was successful in all patients. Twenty-one patients were enrolled consecutively for VasoCT scanning, and incomplete stent apposition was observed in 5 (23.8%). Perioperative complications occurred in 10 patients (9.4%): cerebral infarction in 6, intraoperative coil prolapse in 1, puncture site pseudoaneurysm in 1, deep vein thrombosis at multiple sites in 1, and transient brainstem mass effect in 1. Among the 95 aneurysms with angiographic follow-up, embolization was satisfactory (Raymond-Roy classifications I and II) in 89 (93.7%). Hyperlipidemia was an independent risk factor for incomplete aneurysm occlusion. At the last clinical follow-up, seven patients had a poor clinical outcome (modified Rankin Scale score ≥ 3). Independent risk factors for poor outcomes were preoperative subarachnoid hemorrhage at presentation and cerebral infarction.

Conclusion: Enterprise 2 stent-assisted coiling for treatment of wide-necked intracranial aneurysms showed good safety and efficacy; however, incomplete stent apposition can still occur in vessels with a large curvature. Preoperative subarachnoid hemorrhage at presentation and cerebral infarction are the main reasons for poor clinical outcomes after stent-assisted coil embolization.

背景:本研究通过检查支架血管位置、手术并发症、栓塞结果和临床结果,分析Enterprise 2支架辅助线圈栓塞治疗颅内宽颈动脉瘤的安全性和有效性。方法:回顾性分析2018年11月至2019年10月在我院行Enterprise 2支架辅助卷绕术的颅内宽颈动脉瘤患者的病历。在连续队列患者中,术中血管oct在支架释放后立即进行,以观察支架-血管的相对位置。记录和分析患者的人口统计学、临床和影像学资料。结果:106例宽颈动脉瘤共治疗106例。所有患者支架释放均成功。21例患者连续入组进行VasoCT扫描,5例(23.8%)观察到支架不完全贴置。围术期并发症10例(9.4%):脑梗死6例,术中线圈脱垂1例,穿刺部位假性动脉瘤1例,多部位深静脉血栓形成1例,暂时性脑干肿块效应1例。经血管造影随访的95个动脉瘤中,89个(93.7%)栓塞治疗满意(Raymond-Roy I和II级)。高脂血症是不完全动脉瘤闭塞的独立危险因素。最后一次临床随访时,7例患者临床预后较差(改良Rankin量表评分≥3)。预后不良的独立危险因素是术前出现的蛛网膜下腔出血和脑梗死。结论:Enterprise 2支架辅助盘绕治疗颅内宽颈动脉瘤具有良好的安全性和有效性;然而,在大曲率的血管中仍可能发生支架不完全贴合。术前首发时的蛛网膜下腔出血和脑梗死是支架辅助线圈栓塞术后临床效果较差的主要原因。
{"title":"Effects of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms.","authors":"Yangyang Zhou,&nbsp;Qichen Peng,&nbsp;Shiqing Mu","doi":"10.1186/s41016-022-00298-w","DOIUrl":"https://doi.org/10.1186/s41016-022-00298-w","url":null,"abstract":"<p><strong>Background: </strong>This study analyzed the safety and efficacy of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms by examining stent-vessel apposition, operative complications, embolization outcomes, and clinical outcomes.</p><p><strong>Methods: </strong>We retrospectively reviewed the medical records of patients with wide-necked intracranial aneurysms who underwent Enterprise 2 stent-assisted coiling in our hospital from November 2018 to October 2019. Intraoperative VasoCT was performed immediately after stent release in a continuous cohort of patients to observe stent-vessel apposition. Patient demographic, clinical, and imaging data were recorded and analyzed.</p><p><strong>Results: </strong>A total of 106 wide-necked aneurysms in 106 patients were treated. Stent release was successful in all patients. Twenty-one patients were enrolled consecutively for VasoCT scanning, and incomplete stent apposition was observed in 5 (23.8%). Perioperative complications occurred in 10 patients (9.4%): cerebral infarction in 6, intraoperative coil prolapse in 1, puncture site pseudoaneurysm in 1, deep vein thrombosis at multiple sites in 1, and transient brainstem mass effect in 1. Among the 95 aneurysms with angiographic follow-up, embolization was satisfactory (Raymond-Roy classifications I and II) in 89 (93.7%). Hyperlipidemia was an independent risk factor for incomplete aneurysm occlusion. At the last clinical follow-up, seven patients had a poor clinical outcome (modified Rankin Scale score ≥ 3). Independent risk factors for poor outcomes were preoperative subarachnoid hemorrhage at presentation and cerebral infarction.</p><p><strong>Conclusion: </strong>Enterprise 2 stent-assisted coiling for treatment of wide-necked intracranial aneurysms showed good safety and efficacy; however, incomplete stent apposition can still occur in vessels with a large curvature. Preoperative subarachnoid hemorrhage at presentation and cerebral infarction are the main reasons for poor clinical outcomes after stent-assisted coil embolization.</p>","PeriodicalId":36700,"journal":{"name":"Chinese Neurosurgical Journal","volume":" ","pages":"29"},"PeriodicalIF":0.0,"publicationDate":"2022-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40387961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Chinese Neurosurgical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1